Dyadic International, Inc.
Dyadic International, Inc.
Dyadic International, Inc.
DYAI
DYAI
Nasdaq
Health Services
Medical/Nursing Services
1.19
USD
-0.02
-1.65%
Fechado: 07-24 20:00 (UTC+0)
1.19
USD
+0.0559
+4.70%
Pós-fechamento: 07-25 00:00 (UTC+0)

DYAI Estatísticas principais

Alta
1.26
Abrir
1.21
Volume
105.18K
Baixa
1.12
Fechamento anterior
1.21
Valor negociado
125.54K
52 sem. máx.
1.60
Vol. relativo
0.371
Amplitude (%)
11.49%
52 sem. mín.
0.65
Taxa de giro
0.29%
Cap. de Mercado
43.36M
P/L (TTM)
--
P/L (Anual)
--
P/VP
-106.35
P/S
11.39
Lucro por ação (EPS)
-0.214
Dividendo (TTM)
0
Rendimento de dividendos
0.00%
Ações em circulação
36.43M
Unidade monetária
USD

DYAI Desempenho de Preço

7 dia
30 dia
90 dia
180 dia
No acumulado do ano
1 Ano
DYAI Distribuição do fluxo de dinheiro
DYAI Volume diário de venda a descoberto
DYAI Histórico de short interest
As of 2026-07-26, the Dyadic International, Inc. (DYAI) stock price today is 1.19. Based on this price, the company has a market capitalization of $43.36M, with a P/E ratio of --. On 2026-07-26, DYAI traded between 1.12 and 1.26. Today’s stock price is 6.25% above the daily low and 5.56% below the daily high, placing DYAI perto do meio de its most recent trading range. Trading volume currently stands at 105.18K, compared with an average daily volume of 283.91K. This suggests that trading activity is significativamente abaixo do nível habitual than usual. Over the past year, Dyadic International, Inc. shares have traded between 0.65 and 1.60. At today’s price, DYAI is 83.08% above its 52-week low and 25.63% below its 52-week high.
Nome empresa
Dyadic International, Inc.
Setor
Health Services
Indústria
Medical/Nursing Services
Trocas
Nasdaq
Número de funcionários
5
Tamanho do lote
100
Site oficial
Unidade monetária
USD
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

DYAI FAQ

Pesquisar
Mais